29th January 2021 Missed our free GatewayC LIVE webinar? Watch our recording here. In this webinar, GatewayC met Professor Robert Duncombe, Director of Pharmacy at The Christie NHS Foundation Trust and Dr Neil Bayman, Consultant Clinical Oncologist and Associate...
Monday 18th January 2021 GatewayC have produced a list of cancer charity support lines for people who may be worried about their cancer diagnosis, or are concerned about how COVID-19 might affect their cancer treatment. Please download this PDF resource or find the...
Potential pitfall: Jaundice can be a classic symptom of pancreatic cancer; about half of patients have jaundice when they first go to their GP. Yet, pancreatic cancer is difficult to diagnose as symptoms can vary or may be late, vague and non-specific. Helpful hint:...
Potential pitfall: Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It is therefore not...
If you are suspicious of myeloma following blood results, there are two pertinent investigations that can be ordered in primary care to give a strong case for referral:
1. Serum protein electrophoresis test
2. Bence-Jones protein urine test
If you test for serum protein electrophoresis alone, you will identify only 2/3 of patients.
Most patients with untreated myeloma have a monoclonal immunoglobulin peak in serum, urine, or both. A combination of serum protein electrophoresis and Bence-Jones protein urine test will diagnose up to 95% of patients with myeloma without any form of imaging. NICE NG12 guidelines suggest making a suspected cancer referral for patients whose investigation results indicate myeloma.
Download this Cancer Key here.
Access GatewayC’s Myeloma – Early Diagnosis course.
29th January 2021 Missed our free GatewayC LIVE webinar? Watch our recording here. In this webinar, GatewayC met Professor Robert Duncombe, Director of Pharmacy at The Christie NHS Foundation Trust and Dr Neil Bayman, Consultant Clinical Oncologist and Associate...
Monday 18th January 2021 GatewayC have produced a list of cancer charity support lines for people who may be worried about their cancer diagnosis, or are concerned about how COVID-19 might affect their cancer treatment. Please download this PDF resource or find the...
Potential pitfall: Jaundice can be a classic symptom of pancreatic cancer; about half of patients have jaundice when they first go to their GP. Yet, pancreatic cancer is difficult to diagnose as symptoms can vary or may be late, vague and non-specific. Helpful hint:...
Potential pitfall: Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It is therefore not...